Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Erythromelalgia as a manifestation of autonomic nervous system involvement in multiple sclerosis.
Switching or Discontinuing Disease-Modifying Therapies for Multiple Sclerosis.
CFHR1-Modified Neural Stem Cells Ameliorated Brain Injury in a Mouse Model of Neuromyelitis Optica Spectrum Disorders.
Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers.
Effects of a home-based upper-limb training program in patients with Multiple Sclerosis: a randomized controlled trial.
Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.
Monoclonal gammopathy of undeterminated significance and endoneurial IgG deposition: A case report.
The MS Center of Saint Louis: a practice perspective of the impacts of high cost sharing.
Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders.
Implementation of a Coherent Anti-Stokes Raman Scattering (CARS) System on a Ti:Sapphire and OPO Laser Based Standard Laser Scanning Microscope.
Phenytoin for neuroprotection - Authors' reply.
The effect of vibrotactile biofeedback of trunk sway on balance control in multiple sclerosis.
Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.
Receipt of recommended services among patients with selected disabling conditions and diabetes.
Angiotensin-converting enzyme insertion/deletion gene polymorphism in multiple sclerosis: a meta-analysis.
MHC class II isotype- and allele-specific attenuation of experimental autoimmune encephalomyelitis.
No evidence of disease activity in multiple sclerosis patients.
Mitochondrial dysfunction and neurodegeneration in multiple sclerosis.
Synaptic Pathology in the Cerebellar Dentate Nucleus in Chronic Multiple Sclerosis.
[Assessment of severity of neurogenic bowel dysfunction in chronic patients with a simple 1-item questionnaire (PGI-S)].
Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.
S100A8/A9: From basic science to clinical application.
Potential treatment mechanisms in a mindfulness-based intervention for people with progressive multiple sclerosis.
Corrigendum: Oligodendrocyte, Astrocyte and Microglia Crosstalk in Myelin Development, Damage, and Repair.
Brain-derived neurotrophic and immunologic factors: beneficial effects of riboflavin on motor disability in murine model of multiple sclerosis.

Pages